Ulla Feldt-Rasmussen

Ulla Feldt-Rasmussen

Clinical Professor


Publication year:
All
1 - 10 out of 20Page size: 10
Sort by: Title
  1. Published

    Validation of a novel automated system, Fluispotter®, for serial sampling of dried blood spots

    Krogh, Jesper, Plomgaard, Peter Stendahl, Frikke-Schmidt, Ruth, Velschow, S., Johannesen, Jesper, Hilsted, L. M., Schrøder, M. & Feldt-Rasmussen, Ulla, 2023, In: Endocrine Connections. 12, 7, 9 p., e230087.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Thyroglobulin Antibodies in Women with Recurrent Pregnancy Loss: A Systematic Review and Meta-Analysis

    Huisman, P., Krogh, Jesper, Nielsen, C. H., Nielsen, Henriette Svarre, Feldt-Rasmussen, Ulla & Bliddal, S., 2023, In: Thyroid. 33, 11, p. 1287-1301 15 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Survival and long-term socioeconomic consequences of childhood and adolescent onset of brain tumours

    Pickering, L., Main, Katharina Maria, Feldt-Rasmussen, Ulla, Sehested, A., Mathiasen, R., Klose, M., Ibsen, R., Kjellberg, J. & Jennum, Poul, 2023, In: Developmental Medicine and Child Neurology. 65, 7, p. 942-952

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Sex difference in patients with controlled acromegaly—A multicentre survey

    Dal, J., Rosendal, C., Karmisholt, J., Feldt-Rasmussen, Ulla, Andersen, M. S., Klose, M., feltoft, C., Heck, A., Nielsen, E. H. & Jørgensen, J. O. L., 2023, In: Clinical Endocrinology. 98, 1, p. 74-81

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Severity of hypothyroidism is inversely associated with impaired quality of life in patients referred to an endocrine clinic

    Larsen, C. B., Winther, K. H., Cramon, P. K., Rasmussen, Å. K., Feldt-Rasmussen, Ulla, Grønvold, Mogens, Bjørner, Jakob Bue, Hegedüs, L., Watt, Torquil & Bonnema, S. J., 2023, In: Thyroid Research. 16, 1, 10 p., 37.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Accepted/In press

    Risks of suboptimal and excessive thyroid hormone replacement across ages

    Feldt-Rasmussen, Ulla, Effraimidis, G., Bliddal, S. & Klose, M., 2023, (Accepted/In press) In: Journal of Endocrinological Investigation.

    Research output: Contribution to journal › Review › Research › peer-review

  7. Published

    Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A in Denmark 1930–2021: A Nationwide Population-Based Retrospective Study

    Holm, M., Vestergaard, P., Poulsen, M. M., Rasmussen, Å. K., Feldt-Rasmussen, Ulla, Bay, M., Rolighed, L., Londero, S., Pedersen, H. B., Hahn, Christoffer Holst, Rask, K. B., Nielsen, H. H., Gaustadnes, M., Rossing, M. C., Hermann, A. P., Godballe, C. & Mathiesen, J. S., 2023, In: Cancers. 15, 7, 16 p., 2125.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Polyautoimmunity in patients with cutaneous lupus erythematosus: A nationwide sex- and age-matched cohort study from Denmark

    Graven-Nielsen, C. S., Vittrup, I. V., Kragh, A. J., Lund, F., Bliddal, S., Kofoed, K., Kristensen, S., Stensballe, A., Nielsen, C. H., Feldt-Rasmussen, Ulla, Cordtz, R. & Dreyer, L., 2023, In: JAAD International. 13, p. 126-133 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    OUR AIM IS TRUE AND ON TARGET - THE INITIAL DANISH EXPERIENCE ON TARGETED THERAPY IN ERDHEIM-CHESTER DISEASE

    Bjørn, J., Brooks, Patrick Terrence, Svenstrup, M., Feldt-Rasmussen, Ulla, Schramm, T. K., Albrecht-Beste, Elisabeth, Andersen, K. F., Andersen, Christen Bertel L, Ostrowski, Sisse Rye, Brittain, J. M. & Fassi, Daniel El , 2023, In: Pediatric Blood & Cancer. 70, Supplement 1, p. S5 1 p.

    Research output: Contribution to journal › Conference abstract in journal › Research

  10. Published

    Long-term safety and efficacy of pegunigalsidase alfa administered every 4 weeks in patients with Fabry disease: Two-year interim results from the ongoing phase 3 BRIGHT51 open-label extension study

    Bernat, J., Holida, M. D., Longo, N., Goker-alpan, O., Wallace, E., Deegan, P. B., Tøndel, C., Eyskens, F. J., Feldt-Rasmussen, Ulla, Hughes, D., Pisani, A., Rocco, R., Almon, E. B., Alon, S., Chertkoff, R., Warnock, D. G., Waldek, S. & Wilcox, W. R., 2023, In: Molecular Genetics and Metabolism. 138, 2, p. 16 1 p., 107027.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Previous 1 2 Next

ID: 916030